Xi'an Xice Testing Technology Co., Ltd. (SHE:301306)
China · Delayed Price · Currency is CNY 167.55
-6.45 (-3.71%)
Jun 22, 2026, 4:00 PM EDT
SHE:301306 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 305.79 | 321.34 | 386.71 | 288.15 | 302.91 | 243.5 |
Other Revenue | 2.5 | 2.5 | 2.1 | 2.94 | 1.24 | 2.03 |
| 308.29 | 323.84 | 388.81 | 291.09 | 304.15 | 245.53 | |
Revenue Growth (YoY) | -13.45% | -16.71% | 33.57% | -4.29% | 23.87% | 21.43% |
Cost of Revenue | 266.7 | 282.18 | 359.87 | 203.21 | 144.46 | 100.06 |
Gross Profit | 41.59 | 41.66 | 28.94 | 87.89 | 159.69 | 145.47 |
Selling, General & Admin | 118.54 | 114.99 | 114.59 | 113.82 | 72.91 | 56.57 |
Research & Development | 22.49 | 21.04 | 18.14 | 19.28 | 16.86 | 10.61 |
Other Operating Expenses | 0.08 | 0.07 | 0.7 | -0.11 | -1.54 | 1.12 |
Operating Expenses | 164.79 | 150.22 | 150.74 | 153.97 | 100.15 | 71.74 |
Operating Income | -123.2 | -108.56 | -121.8 | -66.08 | 59.54 | 73.74 |
Interest Expense | -12.57 | -12.5 | -11.41 | -5.9 | -3.61 | -2.23 |
Interest & Investment Income | 0.51 | 0.51 | 5.37 | 16.52 | 8.78 | 2.34 |
Currency Exchange Gain (Loss) | 0.77 | 0.77 | -0.37 | -0.13 | 0 | 0.13 |
Other Non Operating Income (Expenses) | -0.97 | -0.98 | -0.29 | -0.51 | -0.04 | -0.31 |
EBT Excluding Unusual Items | -135.46 | -120.76 | -128.5 | -56.1 | 64.67 | 73.67 |
Impairment of Goodwill | - | - | - | - | -2.9 | - |
Gain (Loss) on Sale of Investments | 0.44 | 0.01 | 0.02 | 1.24 | 0.32 | -0.19 |
Gain (Loss) on Sale of Assets | 0.09 | 0.1 | 0.14 | 0.45 | 0.02 | -0.45 |
Asset Writedown | -11.51 | -6.38 | -20.42 | -0.23 | - | - |
Other Unusual Items | 4.45 | 4.42 | -2.28 | 5.48 | 19.48 | 6.3 |
Pretax Income | -141.99 | -122.62 | -151.05 | -49.16 | 81.59 | 79.33 |
Income Tax Expense | 4.59 | 4.06 | 3.43 | -0.47 | 15.8 | 11.76 |
Earnings From Continuing Operations | -146.58 | -126.67 | -154.48 | -48.69 | 65.78 | 67.58 |
Minority Interest in Earnings | -2.61 | -3.57 | -3.79 | -3.01 | -1.12 | -0.53 |
Net Income | -149.19 | -130.24 | -158.27 | -51.7 | 64.67 | 67.05 |
Net Income to Common | -149.19 | -130.24 | -158.27 | -51.7 | 64.67 | 67.05 |
Net Income Growth | - | - | - | - | -3.55% | 34.84% |
Shares Outstanding (Basic) | 85 | 85 | 84 | 85 | 72 | 63 |
Shares Outstanding (Diluted) | 85 | 85 | 84 | 85 | 72 | 63 |
Shares Change (YoY) | 1.04% | 0.46% | -0.67% | 17.95% | 13.60% | 3.99% |
EPS (Basic) | -1.76 | -1.54 | -1.88 | -0.61 | 0.90 | 1.06 |
EPS (Diluted) | -1.76 | -1.54 | -1.88 | -0.61 | 0.90 | 1.06 |
EPS Growth | - | - | - | - | -15.09% | 29.67% |
Free Cash Flow | -183.55 | -212.39 | -309.13 | -363.37 | -49.34 | -14.81 |
Free Cash Flow Per Share | -2.16 | -2.51 | -3.67 | -4.29 | -0.69 | -0.23 |
Dividend Per Share | - | - | - | - | 0.150 | - |
Gross Margin | 13.49% | 12.86% | 7.44% | 30.19% | 52.50% | 59.25% |
Operating Margin | -39.96% | -33.52% | -31.33% | -22.70% | 19.57% | 30.03% |
Profit Margin | -48.39% | -40.22% | -40.71% | -17.76% | 21.26% | 27.31% |
Free Cash Flow Margin | -59.54% | -65.59% | -79.51% | -124.83% | -16.22% | -6.03% |
EBITDA | -64.53 | -52.57 | -76.57 | -40.33 | 78.24 | 89.25 |
EBITDA Margin | -20.93% | -16.23% | -19.69% | -13.85% | 25.72% | 36.35% |
D&A For EBITDA | 58.68 | 55.99 | 45.23 | 25.76 | 18.71 | 15.51 |
EBIT | -123.2 | -108.56 | -121.8 | -66.08 | 59.54 | 73.74 |
EBIT Margin | -39.96% | -33.52% | -31.33% | -22.70% | 19.57% | 30.03% |
Effective Tax Rate | - | - | - | - | 19.37% | 14.82% |
Revenue as Reported | 308.29 | 323.84 | 388.81 | 291.09 | 304.15 | 245.53 |
Advertising Expenses | - | 0.39 | 1.03 | - | - | - |